ASPG and hemophagocytic syndrome: The DEP regimen (a combination of liposomal doxorubicin, etoposide, and methylprednisolone), with or without asparaginase, has shown significant efficacy in adult patients with refractory HLH.457–459 In recent years, several targeted therapies have emerged for HLH treatment.